Encompass Health (EHC) to Release Earnings on Monday

Encompass Health (NYSE:EHC) is scheduled to be announcing its earnings results after the market closes on Monday, October 28th. Analysts expect the company to announce earnings of $0.94 per share for the quarter. Encompass Health has set its FY24 guidance at $3.97-$4.22 EPS.Parties that wish to register for the company’s conference call can do so using this link.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Monday, August 5th. The company reported $1.11 earnings per share for the quarter, topping the consensus estimate of $1.01 by $0.10. The company had revenue of $1.30 billion during the quarter, compared to analysts’ expectations of $1.30 billion. Encompass Health had a net margin of 7.88% and a return on equity of 17.83%. Encompass Health’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the prior year, the company posted $0.95 earnings per share. On average, analysts expect Encompass Health to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Encompass Health Price Performance

EHC stock opened at $97.19 on Monday. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 1.08. The company’s fifty day simple moving average is $92.85 and its 200 day simple moving average is $87.85. Encompass Health has a 12-month low of $57.55 and a 12-month high of $98.74. The firm has a market cap of $9.79 billion, a price-to-earnings ratio of 26.27, a PEG ratio of 1.43 and a beta of 0.88.

Encompass Health announced that its board has approved a stock repurchase program on Wednesday, July 24th that allows the company to buyback $500.00 million in shares. This buyback authorization allows the company to reacquire up to 5.4% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s board of directors believes its stock is undervalued.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.70%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health’s dividend payout ratio is 18.38%.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on EHC. Stephens reissued an “overweight” rating and set a $105.00 target price on shares of Encompass Health in a research note on Tuesday, August 6th. UBS Group increased their price objective on shares of Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, September 25th. Leerink Partners assumed coverage on Encompass Health in a research report on Wednesday, July 10th. They issued an “outperform” rating and a $100.00 target price for the company. Truist Financial upped their price target on Encompass Health from $104.00 to $108.00 and gave the stock a “buy” rating in a research note on Monday, October 14th. Finally, Barclays reduced their price objective on Encompass Health from $113.00 to $109.00 and set an “overweight” rating for the company in a research note on Tuesday, August 6th. Eight equities research analysts have rated the stock with a buy rating and three have given a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $104.67.

Insiders Place Their Bets

In other news, CFO Douglas E. Coltharp sold 12,260 shares of the firm’s stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $86.34, for a total value of $1,058,528.40. Following the transaction, the chief financial officer now owns 136,227 shares in the company, valued at $11,761,839.18. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 2.10% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.